PTEN Expression Causes Feedback Upregulation of Insulin Receptor Substrate 2

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2001 May 22

PMID 11359902

Citations 21

Authors

L Simpson

J Li

D Liaw

I Hennessy

J Oliner

F Christians

R Parsons

Affiliations

Soon will be listed here.

Abstract

PTEN is a tumor suppressor that antagonizes phosphatidylinositol-3 kinase (PI3K) by dephosphorylating the D3 position of phosphatidylinositol (3,4,5)-triphosphate (PtdIns-3,4,5-P3). Given the importance of PTEN in regulating PtdIns-3,4,5-P3 levels, we used Affymetrix GeneChip arrays to identify genes regulated by PTEN. PTEN expression rapidly reduced the activity of Akt, which was followed by a G(1) arrest and eventually apoptosis. The gene encoding insulin receptor substrate 2 (IRS-2), a mediator of insulin signaling, was found to be the most induced gene at all time points. A PI3K-specific inhibitor, LY294002, also upregulated IRS-2, providing evidence that it was the suppression of the PI3K pathway that was responsible for the message upregulation. In addition, PTEN, LY294002, and rapamycin, an inhibitor of mammalian target of rapamycin, caused a reduction in the molecular weight of IRS-2 and an increase in the association of IRS-2 with PI3K. Apparently, PTEN inhibits a negative regulator of IRS-2 to upregulate the IRS-2-PI3K interaction. These studies suggest that PtdIns-3,4,5-P3 levels regulate the specific activity and amount of IRS-2 available for insulin signaling.

Citing Articles

miR-320b, a Future Expected New Biomarker for Type 2 Diabetes Mellitus Induces Dysglycemia by Targeting PTEN.

Wang J, Tao R, Hu H, Gao J, Liu Y, Xia J Int J Endocrinol. 2024; 2024:5540062.

PMID: 39502509 PMC: 11535181. DOI: 10.1155/2024/5540062.

OVEREXPRESSION OF PTEN GENE INCREASES INS2 GENE MRNA EXPRESSION, NOT INS1 GENE MRNA EXPRESSION, IN INSULINOMA CELL LINE RIN-5F.

Kiba T Acta Endocrinol (Buchar). 2024; 19(3):277-280.

PMID: 38356984 PMC: 10863969. DOI: 10.4183/aeb.2023.277.

Recapitulation of anti-aging phenotypes by global overexpression of PTEN in mice.

Hager M, Chang P, Lee M, Burns C, Endicott S, Miller R Geroscience. 2023; 46(2):2653-2670.

PMID: 38114855 PMC: 10828233. DOI: 10.1007/s11357-023-01025-8.

Identification and panoramic analysis of drug response-related genes in triple negative breast cancer using as an example NVP-BEZ235.

Feng J, Wang L, Zhang K, Ni S, Li B, Liu J Sci Rep. 2023; 13(1):5984.

PMID: 37045929 PMC: 10097725. DOI: 10.1038/s41598-023-32757-4.

Effects of Chronic Arginase Inhibition with Norvaline on Tau Pathology and Brain Glucose Metabolism in Alzheimer's Disease Mice.

Polis B, Squillario M, Gurevich V, Srikanth K, Assa M, Samson A Neurochem Res. 2022; 47(5):1255-1268.

PMID: 35098420 DOI: 10.1007/s11064-021-03519-3.

References

Yenush L, White M . The IRS-signalling system during insulin and cytokine action. Bioessays. 1997; 19(6):491-500. DOI: 10.1002/bies.950190608. View

Li J, DeFea K, Roth R . Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway. J Biol Chem. 1999; 274(14):9351-6. DOI: 10.1074/jbc.274.14.9351. View

Risinger J, Hayes A, Berchuck A, Barrett J . PTEN/MMAC1 mutations in endometrial cancers. Cancer Res. 1997; 57(21):4736-8. View

Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H . A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine.... J Biol Chem. 1997; 272(47):29911-8. DOI: 10.1074/jbc.272.47.29911. View

He T, Zhou S, DA COSTA L, Yu J, Kinzler K, Vogelstein B . A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A. 1998; 95(5):2509-14. PMC: 19394. DOI: 10.1073/pnas.95.5.2509. View

Lynch E, Ostermeyer E, Lee M, Arena J, Ji H, Dann J . Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. Am J Hum Genet. 1997; 61(6):1254-60. PMC: 1716102. DOI: 10.1086/301639. View

Withers D, Gutierrez J, Towery H, Burks D, Ren J, Previs S . Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 1998; 391(6670):900-4. DOI: 10.1038/36116. View

Maehama T, Dixon J . The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1998; 273(22):13375-8. DOI: 10.1074/jbc.273.22.13375. View

Rother K, Imai Y, Caruso M, Beguinot F, Formisano P, Accili D . Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J Biol Chem. 1998; 273(28):17491-7. DOI: 10.1074/jbc.273.28.17491. View

10.

Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi P . Pten is essential for embryonic development and tumour suppression. Nat Genet. 1998; 19(4):348-55. DOI: 10.1038/1235. View

11.

Razzini G, Ingrosso A, Brancaccio A, Sciacchitano S, Esposito D, Falasca M . Different subcellular localization and phosphoinositides binding of insulin receptor substrate protein pleckstrin homology domains. Mol Endocrinol. 2000; 14(6):823-36. DOI: 10.1210/mend.14.6.0486. View

12.

Vazquez F, Ramaswamy S, Nakamura N, Sellers W . Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol. 2000; 20(14):5010-8. PMC: 85951. DOI: 10.1128/MCB.20.14.5010-5018.2000. View

13.

Shimomura I, Matsuda M, Hammer R, Bashmakov Y, Brown M, Goldstein J . Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell. 2000; 6(1):77-86. View

14.

Michael M, Kulkarni R, Postic C, Previs S, Shulman G, Magnuson M . Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell. 2000; 6(1):87-97. View

15.

Serunian L, Auger K, Cantley L . Identification and quantification of polyphosphoinositides produced in response to platelet-derived growth factor stimulation. Methods Enzymol. 1991; 198:78-87. DOI: 10.1016/0076-6879(91)98010-4. View

16.

Momand J, Zambetti G, Olson D, George D, Levine A . The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 1992; 69(7):1237-45. DOI: 10.1016/0092-8674(92)90644-r. View

17.

Sun X, Miralpeix M, Myers Jr M, Glasheen E, Backer J, Kahn C . Expression and function of IRS-1 in insulin signal transmission. J Biol Chem. 1992; 267(31):22662-72. View

18.

Oliner J, Pietenpol J, Thiagalingam S, Gyuris J, Kinzler K, Vogelstein B . Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature. 1993; 362(6423):857-60. DOI: 10.1038/362857a0. View

19.

Tanti J, Gremeaux T, Van Obberghen E, Le Marchand-Brustel Y . Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol Chem. 1994; 269(8):6051-7. View

20.

Sepp-Lorenzino L, Rosen N, Lebwohl D . Insulin and insulin-like growth factor signaling are defective in the MDA MB-468 human breast cancer cell line. Cell Growth Differ. 1994; 5(10):1077-83. View